Status:

COMPLETED

Development of Fluid Intake App for Management of Fluid Intake During Hemodialysis

Lead Sponsor:

Wake Forest University Health Sciences

Collaborating Sponsors:

Danone Global Research & Innovation Center

Conditions:

Weight Gain

Eligibility:

All Genders

18+ years

Phase:

NA

Brief Summary

Methods are needed to help decrease interdialytic weight gains in hemodialysis patients. One potential method for accomplishing this goal is to develop an app for smartphones that allow patients to tr...

Detailed Description

For the Vanguard phase of the trial, a survey will be used to assess the usability of the app as well as to collect recommendations for changes to the app itself (appendix one). For this Vanguard phas...

Eligibility Criteria

Inclusion

  • Subject, upon briefing of the content of the present study, fully understanding and agreeing to its objective and having given written (dated and signed) informed consent form to take part in the study.
  • Adult chronic hemodialysis patients who are at least 18 years of age
  • Average interdialytic fluid gains of less than 4% of body weight for both weekdays and weekends for a 30 day period
  • Access to a smartphone for use of the app and comfort with using apps on a regular basis
  • Access to a smartphone running under either iOS or Android operating systems
  • Sufficient knowledge and understanding of the English language to use the application available only in English (US) language
  • Mental capacity to use and understand the fluid management app
  • Willingness to share intake data collected with the research team

Exclusion

  • Scheduled for a living related renal transplant in the next four months
  • Class III or IV heart failure
  • Need for chronic oxygen therapy due to pulmonary disease
  • Hospitalization within 30 days of entry into the study
  • Current participation in a randomized clinical trial or in the exclusion period of another clinical trial

Key Trial Info

Start Date :

January 23 2019

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

September 21 2023

Estimated Enrollment :

28 Patients enrolled

Trial Details

Trial ID

NCT03759847

Start Date

January 23 2019

End Date

September 21 2023

Last Update

January 9 2024

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Wake Forest University Health Sciences

Winston-Salem, North Carolina, United States, 27157